🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for DNA

Mitochondrial DNA Signatures of Poor Aerobic Exercise Trainability in Young Adults Born Preterm NCT06334107NA1 site📍 Lubbock Texas Tech University · Tests: Exercise "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site📍 Zhuhai Ming-Yuan Chen · Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participants… T-cell Therapy in Patients With PML NCT06990087Phase 27 sites📍 München📍 Marburg📍 Hanover Hannover Medical School · Tests: Application of T-lymphocytes Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia NCT05281809Phase 21 site📍 Pittsburgh John Lister · Tests: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites📍 Bordeaux📍 Caen📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Main study:, Sub-study: cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847NA4 sites📍 Aurillac📍 Clermont-Ferrand📍 Lyon Centre Jean Perrin · Tests: blood sampling PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation NCT04901884NA1 site📍 Toronto University Health Network, Toronto · Tests: PET/MR with 18F-FDG CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies NCT07106749Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: CD180 CART A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation NCT07531784n/a1 site📍 Stockholm Karolinska Institutet · Tests: dd-cfDNA Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX) NCT05784038n/a3 sites📍 Belém📍 São Paulo📍 Rio de Janeiro Hospital Israelita Albert Einstein · Tests: Viral genomic, Untargeted Metabolomics Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site📍 Memphis St. Jude Children's Research Hospital TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" NCT07381764Phase 226 sites📍 Alessandria📍 Ancona📍 Aviano Gruppo Oncologico Italia Meridionale · Tests: Erbitux (Cetuximab), Bevacizumab, Irinotecan, Trifluridine/tipiracil The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor NCT06863844n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Blinatumomab Consolidation in Real World NCT07117136n/a5 sites📍 Jacksonville📍 Chicago📍 Chicago Medical College of Wisconsin Prospective ctDNA Testing in Large B-Cell Lymphoma NCT07878351n/a2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Standard-of-care first-line immunochemotherapy containing an anti-CD20 monoclonal antibody and an anthracycline, such a… CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma NCT05054257Phase 11 site📍 Prague Institute of Hematology and Blood Transfusion, Czech Republ… · Tests: Autologous CAR19 T lymphocytes The Drug Rediscovery Protocol (DRUP Trial) NCT02925234Phase 236 sites📍 Alkmaar📍 Almelo📍 Amersfoort The Netherlands Cancer Institute · Tests: Panitumumab, Olaparib, Dabrafenib, Nilotinib, Trametinib ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NCT07084558NA14 sites📍 Vienna📍 Baden📍 Dornbirn Austrian Breast & Colorectal Cancer Study Group · Tests: blood sample for Signatera (TM) test, biopsy for Ki-67 assessment, FFPE tumor sample for Signatera (TM) test (archived) Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis NCT07471373NA1 site📍 Salouël Centre Hospitalier Universitaire, Amiens · Tests: Circulating DNA analysis, Vaginal microbiota analysis, Endometrial microbiota analysis, Intestinal microbiota analysis,… Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia NCT03136146Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone, Etoposide The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients NCT07188480NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: bronchial lavage for NGS analysis Precision Imaging to Evaluate Kaposi Sarcoma NCT06898203NA2 sites📍 Kisumu📍 Kampala Washington University School of Medicine · Tests: SkinScan3D The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture NCT06629766NA1 site📍 Basking Ridge Reproductive Medicine Associates of New Jersey · Tests: Microfluidic sperm separation device, Density grade centrifugation The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases NCT04491929n/a1 site📍 Aarhus N Aarhus University Hospital Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection NCT06351488n/a3 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy